Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Abdominal Pain
SURPASS-4, a multicenter open-label RCT comparing treatment with tirzepatide and insulin glargine in T2D patients at increased CV risk for a median of 85 weeks, was the only study in the SURPASS program to include the change from baseline in eGFR and UACR and occurrence of eGFR decline of at least 40%, renal death, progression to end-stage kidney disease or new-onset MA among the prespecified analyses [48]
Asad Niazi, MD, MPH, is a board-certified physician in Dallas who specializes in weight loss and metabolic health
Cost depends on your dose and plan
Mounjaro is an injectable medication prescribed for adults with type 2 diabetes to help manage their blood sugar levels
The need for and frequency of such tests will be determined by your clinician rather than being routine for everyone
US$ 28.25
US$ 20.09
US$ 23.73
US$ 22.46
US$ 26.72
